DefiniGEN will be attending ASGCT

Posted by on Fri, Sep 27, 2024

Come and meet DefiniGEN at booth #1745 and hear how our iPSC-derived hepatocyte platform (Opti-HEP) can:

  • Be applied to any modality;
  • Is engineered to recapitulate disease phenotypes; and
  • Offers diverse genetic backgrounds for screening.